Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 1, 2009, Pages 16-21

  Bossé, Ynuk ^a,c   Stankova, Jana ^b   Rola Pleszczynski, Marek ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONTELUKAST; PEPTIDOLEUKOTRIENE; PRANLUKAST; SB 210661; SD 282; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERLUKAST; ZAFIRLUKAST;

AIRWAY; AIRWAY SMOOTH MUSCLE CELL HYPERPLASIA; ALLERGIC ASTHMA; ASTHMA; BREATHING MUSCLE; CELL HYPERPLASIA; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; IN VIVO STUDY; INFLAMMATORY CELL; MITOGENESIS; MUSCLE FIBER CULTURE; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOOTH MUSCLE FIBER;

EID: 59449100937     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60102-0     Document Type: Review

References (50)

1. Capra V. Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res. 2004;50:1-11.
2. Powell WS, Xu LJ, Martin JG. Effects of dexamethasone on leukotriene synthesis and airway responses to antigen and leukotriene D4 in rats. Am J Respir Crit Care Med. 1995;151:1143-1150.
3. Henderson WR Jr, Lewis DB, Albert RK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med. 1996;184:1483-1494.
4. Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol. 1988;81:711-717.
5. Sampson AP, Castling DP, Green CP, Price JF. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child. 1995;73:221-225.
6. Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax. 2004;59:100-104.
7. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834-846.
8. Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med. 1999;160:1905-1909.
9. Csoma Z, Kharitonov SA, Balint B, et al. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002;166:1345-1349.
10. Mewes T, Riechelmann H, Klimek L. Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy. 1996;51:506-510.
11. Zhu J, Qiu YS, Figueroa DJ, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol. 2005;33:531-540.
12. Amrani Y, Moore PE, Hoffman R, Shore SA, Panettieri RA Jr. Inter- feron-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am J Respir Crit Care Med. 2001;164:2098-2101.
13. Weiss JW, Drazen JM, Coles N, et al. Bronchoconstrictor effects of leukotriene C in humans. Science. 1982;216:196-198.
14. Hay DW, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci. 1995;16:304-309.
15. Irvin CG, Tu YP, Sheller JR, Funk CD. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol. 1997;272(6 Pt 1):L1053-L1058.
16. Kim DC, Hsu FI, Barrett NA, et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol. 2006;176:4440-4448.
17. Salmon M, Walsh DA, Huang TJ, et al. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br J Pharmacol. 1999;127:1151-1158.
18. Wang CG, Du T, Xu LJ, Martin JG. Role of leukotriene D4 in allergen- induced increases in airway smooth muscle in the rat. Am Rev Respir Dis. 1993;148:413-417.
19. Henderson WR Jr, Tang LO, Chu SJ, et al. A role for cysteinyl leuko- trienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 2002;165:108-116.
20. Muz MH, Deveci F, Bulut Y, et al. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Exp Mol Med. 2006;38: 109-118.
21. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest. 2005;127:1312-1326.
22. Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet. 1991;337:690-694.
23. Reiss TF, Hill JB, Harman E, et al. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax. 1997; 52:1030-1035.
24. Rorke S, Jennison S, Jeffs JA, et al. Role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma. Thorax. 2002;57:323-327.
25. Rasmussen JB, Eriksson LO, Tagari P, Stahl EG, Andersson KE. Reduced nonspecific bronchial reactivity and decreased airway response to antigen challenge in atopic asthmatic patients treated with the inhaled leukotriene D4 antagonist, L-648,051. Allergy. 1992;47:604- 609.
26. Dahlen SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:9-14.
27. Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006;96:731-735.
28. Kim SH, Oh JM, Kim YS, et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy. 2006;36:433-439.
29. Noveral JP, Grunstein MM. Role and mechanism of thromboxane- induced proliferation of cultured airway smooth muscle cells. Am J Physiol. 1992;263(5 Pt 1):L555-L561.
30. Cohen P, Noveral JP, Bhala A, et al. Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol. 1995;269(2 Pt 1):L151-L157.
31. Rajah R, Katz L, Nunn S, et al. Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Prog Growth Factor Res. 1995;6:273-284.
32. Rajah R, Nunn SE, Herrick DJ, Grunstein MM, Cohen P. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am J Physiol. 1996;271(6 Pt 1): L1014-L1022.
33. Panettieri RA, Tan EM, Ciocca V, et al. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol. 1998;19:453-461.
34. Ravasi S, Citro S, Viviani B, Capra V, Rovati GE. CysLT1 receptor- induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation. Respir Res. 2006;7:42.
35. Potter-Perigo S, Baker C, Tsoi C, et al. Regulation of proteoglycan synthesis by leukotriene d4 and epidermal growth factor in bronchial smooth muscle cells. Am J Respir Cell Mol Biol. 2004;30:101-108.
36. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol. 2003;111:1032-1040.
37. Richter M, Sirois P. Effects of eicosanoids, neuromediators and bioactive peptides on murine airways. Eur J Pharmacol. 2000;389:225-234.
38. O'Hickey SP, Arm JP, Rees PJ, Spur BW, Lee TH. The relative responsiveness to inhaled leukotriene E4, methacholine and histamine in normal and asthmatic subjects. Eur Respir J. 1988;1:913-917.
39. Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med. 2004;200:377-389.
40. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-β antibody: effect on the Smad signaling pathway. J Immunol. 2005;174:5774-5780.
41. Leung SY, Niimi A, Noble A, et al. Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD- 208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther. 2006;319:586-594.
42. Cohen MD, Ciocca V, Panettieri RA Jr. TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am J Respir Cell Mol Biol. 1997;16:85-90.
43. Bosse Y, Thompson C, Stankova J, Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 2006;34:746-753.
44. Bosseβ Y, Rola-Pleszczynski M. FGF2 in asthmatic airway-smooth muscle-cell hyperplasia. Trends Mol Med. 2008;14:3-11.
45. Kato Y, Fujisawa T, Nishimori H, et al. Leukotriene D4 induces production of transforming growth factor-beta1 by eosinophils. Int Arch Allergy Immunol. 2005;137(Suppl 1):17-20.
46. Perng DW, Wu YC, Chang KT, et al. Leukotriene C4 induces TGF- beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol. 2006;34:101-107.
47. Bossé Y, Thompson C, McMahon S, et al. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy. 2008;38: 113-121.
48. Thompson C, McMahon S, Bossé Y, et al. Leukotriene D4 upregulates furin expression through cysLT1 receptor signaling. Am J Respir Cell Mol Biol. 2008;39;227-234.
49. Fernandes DJ, Ravenhall CE, Harris T, et al. Contribution of the p38MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen-specific. Br J Pharmacol. 2004;142:1182-1190.
50. Nath P, Leung SY, Williams A, et al. Importance of p38 mitogen- activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur J Pharmacol. 2006;544:160-167.